Elcid Investment (503681)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Stated book value of ₹5,15,880.48 per share vs quoted price of ₹3.53 yields a theoretical P/B of 0.00, implying exceptional asset cover if the NAV is genuine.
• Latest quarter delivered sales of ₹62 Cr and net profit of ₹47 Cr, with reported sales growth of 1,273.76% and profit growth of 787.66%.
• Piotroski F-Score of 7/9 signals relatively sound profitability, leverage, and efficiency metrics.
• P/E of 16.64 and PEG of 0.02 are undemanding if the recent earnings momentum is durable.

Concerns

• Price/market-cap data are inconsistent: ₹3.53 and ₹0 Cr market cap cannot be reconciled with a 52-week range of ₹87,003–₹1,44,500; data reliability undermines the thesis.
• ROE of 0.86% and ROCE of 1.98% show the huge book value is earning very little; the market may rationally keep the stock at a deep discount.
• Dividend yield of 0.02% offers almost no income while waiting for value to be unlocked.
• Debt/equity, promoter holding, and FairStock score are N/A/insufficient, leaving a lack of transparency around governance and capital structure.

AI Analysis

I begin with a red flag: the data shows a book value of ₹5,15,880.48 per share, yet the price is ₹3.53, giving a P/B of 0.00 and a market cap of ₹0 Cr. Graham’s first rule is to get the facts before protecting the downside. A scrip with a 52-week range of ₹87,003–₹1,44,500 cannot logically have a current price of ₹3.53 unless the quote is stale, adjusted, or wrong. If the low price is real, the market is valuing the company at zero even though the latest quarter had sales of ₹62 Cr and net profit of ₹47 Cr. If the higher range is real, I still need an audited net asset value, not just a book-entry figure. Elcid is an investment company, so its moat is the underlying portfolio. It has no operating pricing power; its quality is transparency and liquidity of holdings. The growth numbers are spectacular — sales growth of 1,273.76%, profit growth of 787.66% — but a ROE of 0.86% and ROCE of 1.98% tell me the huge stated capital is earning very little. The Piotroski F-Score of 7/9 is fine, and a P/E of 16.64 with a PEG of 0.02 looks cheap. But I refuse to value a black box. Debt/equity is N/A, promoter holding is N/A, the dividend yield is only 0.02%, and FairStock has insufficient data. This is an asset play, not a compounder. I would need a reliable quote, a detailed NAV statement, and evidence of value-unlocking actions before buying. Price is what you pay; value is what you get — and here I cannot yet trust the price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer